Citadel Advisors’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.3M | Buy |
249,700
+70,200
| +39% | +$11.2M | 0.01% | 1748 |
|
|
2025
Q4 | $31.2M | Buy |
179,500
+74,800
| +71% | +$12.3M | ﹤0.01% | 1861 |
|
|
2025
Q3 | $20M | Buy |
104,700
+67,800
| +184% | +$12.5M | ﹤0.01% | 2336 |
|
|
2025
Q2 | $11M | Buy |
36,900
+21,300
| +137% | +$6.69M | ﹤0.01% | 2901 |
|
|
2025
Q1 | $5.14M | Sell |
15,600
-17,200
| -52% | -$5.2M | ﹤0.01% | 3827 |
|
|
2024
Q4 | $9.55M | Sell |
32,800
-49,300
| -60% | -$15.2M | ﹤0.01% | 3048 |
|
|
2024
Q3 | $28.3M | Buy |
82,100
+31,300
| +62% | +$10.3M | 0.01% | 1728 |
|
|
2024
Q2 | $15.1M | Buy |
50,800
+14,200
| +39% | +$4.82M | ﹤0.01% | 2305 |
|
|
2024
Q1 | $15M | Buy |
36,600
+11,400
| +45% | +$4.42M | ﹤0.01% | 2398 |
|
|
2023
Q4 | $9.11M | Buy |
25,200
+8,900
| +55% | +$3.14M | ﹤0.01% | 2978 |
|
|
2023
Q3 | $5.34M | Buy |
16,300
+2,000
| +14% | +$630K | ﹤0.01% | 3547 |
|
|
2023
Q2 | $4.31M | Sell |
14,300
-67,200
| -82% | -$19.3M | ﹤0.01% | 3871 |
|
|
2023
Q1 | $21.8M | Sell |
81,500
-51,800
| -39% | -$14.9M | ﹤0.01% | 1831 |
|
|
2022
Q4 | $44M | Buy |
133,300
+95,700
| +255% | +$32.5M | 0.01% | 1227 |
|
|
2022
Q3 | $12.4M | Buy |
37,600
+14,700
| +64% | +$4.73M | ﹤0.01% | 2453 |
|
|
2022
Q2 | $6.4M | Sell |
22,900
-9,800
| -30% | -$2.96M | ﹤0.01% | 3359 |
|
|
2022
Q1 | $10.9M | Buy |
32,700
+19,100
| +140% | +$5.88M | ﹤0.01% | 2820 |
|
|
2021
Q4 | $4.33M | Sell |
13,600
-7,700
| -36% | -$2.29M | ﹤0.01% | 4586 |
|
|
2021
Q3 | $5.78M | Buy |
21,300
+1,700
| +9% | +$449K | ﹤0.01% | 4034 |
|
|
2021
Q2 | $4.96M | Sell |
19,600
-23,300
| -54% | -$5.85M | ﹤0.01% | 4449 |
|
|
2021
Q1 | $10M | Buy |
42,900
+200
| +0.5% | +$44.6K | ﹤0.01% | 2958 |
|
|
2020
Q4 | $9.08M | Sell |
42,700
-5,900
| -12% | -$1.22M | ﹤0.01% | 2779 |
|
|
2020
Q3 | $8.9M | Buy |
48,600
+8,000
| +20% | +$1.46M | ﹤0.01% | 2423 |
|
|
2020
Q2 | $7.23M | Buy |
40,600
+4,400
| +12% | +$749K | ﹤0.01% | 2595 |
|
|
2020
Q1 | $5.06M | Sell |
36,200
-43,700
| -55% | -$5.85M | ﹤0.01% | 2687 |
|
|
2019
Q4 | $10.8M | Buy |
79,900
+14,200
| +22% | +$1.79M | ﹤0.01% | 2112 |
|
|
2019
Q3 | $7.21M | Sell |
65,700
-43,200
| -40% | -$5.6M | ﹤0.01% | 2635 |
|
|
2019
Q2 | $15.6M | Buy |
108,900
+78,300
| +256% | +$10.7M | 0.01% | 1672 |
|
|
2019
Q1 | $4.34M | Buy |
30,600
+20,400
| +200% | +$2.76M | ﹤0.01% | 3206 |
|
|
2018
Q4 | $1.19M | Sell |
10,200
-7,700
| -43% | -$1.01M | ﹤0.01% | 5046 |
|
|
2018
Q3 | $2.66M | Buy |
17,900
+5,900
| +49% | +$753K | ﹤0.01% | 3922 |
|
|
2018
Q2 | $1.18M | Buy |
12,000
+4,200
| +54% | +$366K | ﹤0.01% | 4939 |
|
|
2018
Q1 | $633K | Sell |
7,800
-12,500
| -62% | -$1.01M | ﹤0.01% | 5492 |
|
|
2017
Q4 | $1.56M | Buy |
20,300
+10,100
| +99% | +$729K | ﹤0.01% | 3978 |
|
|
2017
Q3 | $701K | Buy |
10,200
+4,900
| +92% | +$319K | ﹤0.01% | 4841 |
|
|
2017
Q2 | $367K | Sell |
5,300
-300
| -5% | -$18.4K | ﹤0.01% | 5573 |
|
|
2017
Q1 | $255K | Buy |
5,600
+1,100
| +24% | +$57.6K | ﹤0.01% | 6124 |
|
|
2016
Q4 | $244K | Sell |
4,500
-4,000
| -47% | -$219K | ﹤0.01% | 5986 |
|
|
2016
Q3 | $496K | Sell |
8,500
-1,000
| -11% | -$55.1K | ﹤0.01% | 4870 |
|
|
2016
Q2 | $474K | Buy |
9,500
+5,700
| +150% | +$305K | ﹤0.01% | 4552 |
|
|
2016
Q1 | $245K | Buy |
3,800
+300
| +9% | +$17.8K | ﹤0.01% | 5361 |
|
|
2015
Q4 | $210K | Sell |
3,500
-10,600
| -75% | -$668K | ﹤0.01% | 5745 |
|
|
2015
Q3 | $971K | Buy |
14,100
+3,000
| +27% | +$223K | ﹤0.01% | 3861 |
|
|
2015
Q2 | $780K | Buy |
11,100
+8,800
| +383% | +$589K | ﹤0.01% | 4317 |
|
|
2015
Q1 | $155K | Buy |
2,300
+1,200
| +109% | +$69.3K | ﹤0.01% | 6445 |
|
|
2014
Q4 | $59K | Sell |
1,100
-2,400
| -69% | -$116K | ﹤0.01% | 7073 |
|
|
2014
Q3 | $148K | Sell |
3,500
-3,500
| -50% | -$155K | ﹤0.01% | 6035 |
|
|
2014
Q2 | $312K | Sell |
7,000
-1,100
| -14% | -$44.6K | ﹤0.01% | 5024 |
|
|
2014
Q1 | $304K | Buy |
8,100
+5,000
| +161% | +$184K | ﹤0.01% | 5002 |
|
|
2013
Q4 | $108K | Sell |
3,100
-200
| -6% | -$6.74K | ﹤0.01% | 5546 |
|
|
2013
Q3 | $117K | Buy |
3,300
+2,600
| +371% | +$96K | ﹤0.01% | 5226 |
|
|
2013
Q2 | $26K | Buy |
+700
| New | +$24.7K | ﹤0.01% | 5954 |
|
Other funds holding MOH
VPM
VCM
Citadel Advisors's MOH Position: Q1 2026 in Review
Citadel Advisors increased its Molina Healthcare (MOH) stake by 11% in Q1 2026, buying an estimated $3.4M and bringing the position to 222,644 shares worth $29.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.
Citadel Advisors first reported a position in MOH in Q2 2013 and has held it in 49 quarters since. The position peaked at $85.5M in Q3 2020. 523 funds tracked by Wall St. Rank hold MOH as of Q1 2026.
- Citadel Advisors held 222,644 shares of Molina Healthcare worth $29.7M as of Q1 2026.
- Citadel Advisors bought 21,358 Molina Healthcare shares in Q1 2026, an estimated $3.4M.
- Molina Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #1879 holding.
- Citadel Advisors first reported a position in Molina Healthcare in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Molina Healthcare position peaked at $85.5M in Q3 2020.
- 523 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.